IND application

BEIJING, China, July 6, 2026 InnoCare Pharma has announced a significant milestone in its oncology pipeline with the first...

HONG KONG, July 6, 2026 Ascletis Pharma Inc. has announced the submission of two Investigational New Drug (IND) applications...

SAN DIEGO, May 7, 2026 Halozyme Therapeutics, Inc. announced a major global collaboration and license agreement with GSK to...

SHANGHAI, China – May 8, 2026 Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that...

PHILADELPHIA and VANCOUVER, British Columbia, May 6, 2026 BriaCell Therapeutics Corp. has received FDA clearance for its Investigational New...

MIAMI, FL, April 24, 2026 Telomir Pharmaceuticals has announced the successful completion of its acquisition of TELI Pharmaceuticals, securing...